Minneapolis Clinical Trials
Cozy Study
SAR443820 is being developed to treat multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
16 nights
3 visits
The purpose of the Cozy Study is to assess the effect of repeated administration of itraconazole on single oral dose of SAR443820.
We have tested this medication (SAR443820) at Nucleus Network previously.
This study has 16 nights/ 17 day consecutive stay in-house at our St. Paul facility plus 1 outpatient visit.
This study has been approved by an independent ethics committee.
Reimbursement for study participation will be provided for time and travel of up to $5,400.
Call Regina at 612-500-7321 or register your interest to discuss your eligibility today!
Eligibility
Age: 18-55
BMI: 18-30
Medication Medications must be stopped 14 days prior to admit; this includes all OTC supplements, vitamins, and prescribed medications except for hormonal contraception or menopausal hormone replacement therapy.
Smoking Status: Must be non-smoker or must smoke less than 10 cigarettes per week and able to refrain during the confinement period
Compensation: $5,400